Vir Biotechnology Inc
VIR
ISIN null / Valor 47821156
Vir Biotechnology Inc
UMushroom community rating:
About company
Vir Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the development of therapies for infectious diseases and cancer. The company's pipeline leverages two primary technology platforms: a next-generation antibody platform and the PRO-XTEN™ protease-releasable masking technology, for which Vir holds exclusive rights from Amunix Pharmaceuticals, a Sanofi subsidiary. These platforms enable Vir to efficiently identify, optimize, and advance therapeutic candidates from initial concepts through clinical development. By focusing on innovative approaches in immunology and oncology, Vir aims to address unmet medical needs with its diverse portfolio of investigational treatments.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
1265 M
Market cap (USD)
5,399,537
Daily traded volume (Shares)
7.445 / 7.27
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
